Hereditary gynaecological malignancies: advances in screening and treatment (Q38067433)

28 August 2017

1 reference

title

Hereditary gynaecological malignancies: advances in screening and treatment (English)

1 reference

28 August 2017

Ann K Folkins

1 reference

28 August 2017

Teri A Longacre

series ordinal

1 reference

28 August 2017

publication date

1 January 2013

1 reference

28 August 2017

1 reference

28 August 2017

1 reference

28 August 2017

1 reference

28 August 2017

page(s)

2-30

1 reference

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

28 August 2017

cites work

1 reference

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

21 January 2018

1 reference

Specific keynote: hereditary ovarian cancer: what we know

21 January 2018

1 reference

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer

21 January 2018

1 reference

Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer

21 January 2018

1 reference

Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer

21 January 2018

1 reference

A high frequent BRCA1 founder mutation identified in the Greenlandic population.

21 January 2018

1 reference

Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000.

21 January 2018

1 reference

A founder mutation of the BRCA1 gene in Western Sweden associated with a high incidence of breast and ovarian cancer

21 January 2018

1 reference

Mutations of the BRCA1 gene in human cancer

21 January 2018

1 reference

Hormone replacement therapy and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.

21 January 2018

1 reference

Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers

21 January 2018

1 reference

Parity, Oral Contraceptives, and the Risk of Ovarian Cancer among Carriers and Noncarriers of aBRCA1orBRCA2Mutation

21 January 2018

1 reference

Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

21 January 2018

1 reference

Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations

21 January 2018

1 reference

A critical re-appraisal of BRCA1 methylation studies in ovarian cancer

21 January 2018

1 reference

Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities

21 January 2018

1 reference

Somatic mutations in the BRCA1 gene in sporadic ovarian tumours.

21 January 2018

1 reference

Minding the gap: the underground functions of BRCA1 and BRCA2 at stalled replication forks

21 January 2018

1 reference

Cancer susceptibility and the functions of BRCA1 and BRCA2

21 January 2018

1 reference

PARP inhibitors in BRCA gene-mutated ovarian cancer and beyond

21 January 2018

1 reference

Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis

21 January 2018

1 reference

Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation.

21 January 2018

1 reference

Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm

21 January 2018

1 reference

Early de novo ovarian carcinoma. A study of fourteen cases.

21 January 2018

1 reference

p53 protein expression in putative precursor lesions of epithelial ovarian cancer.

21 January 2018

1 reference

Comparison of prophylactic oophorectomy specimens from carriers and noncarriers of a BRCA1 or BRCA2 gene mutation. United Kingdom Coordinating Committee on Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group

21 January 2018

1 reference

Histopathologic Features of Ovaries at Increased Risk for Carcinoma

21 January 2018

1 reference

Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds

21 January 2018

1 reference

Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer.

21 January 2018

1 reference

Expression of cell cycle regulatory proteins in ovaries prophylactically removed from Jewish Ashkenazi BRCA1 and BRCA2 mutation carriers: correlation with histopathology.

21 January 2018

1 reference

A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations

21 January 2018

1 reference

The incidence of primary fallopian tube cancer in the United States

21 January 2018

1 reference

Pathologic findings in prophylactic oophorectomy specimens in high-risk women

21 January 2018

1 reference

Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy.

21 January 2018

1 reference

Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers.

21 January 2018

1 reference

Incidental carcinomas in prophylactic specimens in BRCA1 and BRCA2 germ-line mutation carriers, with emphasis on fallopian tube lesions: report of 6 cases and review of the literature

21 January 2018

1 reference

Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction

21 January 2018

1 reference

Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma

21 January 2018

1 reference

High rates of occult fallopian tube cancer diagnosed at prophylactic bilateral salpingo-oophorectomy

21 January 2018

1 reference

Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol

21 January 2018

1 reference

Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.

21 January 2018

1 reference

Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention

21 January 2018

1 reference

TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma--evidence supporting the clonal relationship of the two lesions

21 January 2018

1 reference

A candidate precursor to serous carcinoma that originates in the distal fallopian tube.

21 January 2018

1 reference

The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.

21 January 2018

1 reference

Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers.

21 January 2018

1 reference

The post-reproductive Fallopian tube: better removed?

21 January 2018

1 reference

Serous tubal intraepithelial carcinoma: diagnostic reproducibility and its implications.

21 January 2018

1 reference

Diagnosis of serous tubal intraepithelial carcinoma based on morphologic and immunohistochemical features: a reproducibility study

21 January 2018

1 reference

Validation of an algorithm for the diagnosis of serous tubal intraepithelial carcinoma.

21 January 2018

1 reference

Serous carcinogenesis in the fallopian tube: a descriptive classification.

21 January 2018

1 reference

Transitional cell metaplasia of fallopian tube fimbriae: a potential mimic of early tubal carcinoma in risk reduction salpingo-oophorectomies from women With BRCA mutations

21 January 2018

1 reference

Pathology of ovarian cancers in BRCA1 and BRCA2 carriers

21 January 2018

1 reference

Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry

21 January 2018

1 reference

Prediction of BRCA1 germline mutation status in women with ovarian cancer using morphology-based criteria: identification of a BRCA1 ovarian cancer phenotype

21 January 2018

1 reference

Prevalence of BRCA1 and BRCA2 germ line mutations among women with carcinoma of the fallopian tube

21 January 2018

1 reference

Hereditary ovarian cancer.

21 January 2018

1 reference

The preclinical natural history of serous ovarian cancer: defining the target for early detection

21 January 2018

1 reference

Screening for ovarian cancer by transvaginal ultrasound and serum CA125 measurement in women with a familial predisposition: a prospective cohort study

21 January 2018

1 reference

Influence of ovarian cancer risk status on the diagnostic performance of the serum biomarkers mesothelin, HE4, and CA125.

21 January 2018

1 reference

A prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: design and baseline characteristics: a Gynecologic Oncology Group study

21 January 2018

1 reference

Intercepting early pelvic serous carcinoma by routine pathological examination of the fimbria

21 January 2018

1 reference

Improved survival in non-Ashkenazi Jewish ovarian cancer patients with BRCA1 and BRCA2 gene mutations.

21 January 2018

1 reference

Survival in epithelial ovarian cancer: a multivariate analysis incorporating BRCA mutation status and platinum sensitivity.

21 January 2018

1 reference

Gross genomic alterations and gene expression profiles of high- grade serous carcinoma of the ovary with and without BRCA1 inactivation

21 January 2018

1 reference

Drug therapy for hereditary cancers

21 January 2018

1 reference

Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval

21 January 2018

1 reference

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers

21 January 2018

1 reference

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

21 January 2018

1 reference

Paradigms for primary prevention of ovarian carcinoma

21 January 2018

1 reference

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation

21 January 2018

1 reference

Cancer risk in mutation carriers of DNA-mismatch-repair genes

21 January 2018

1 reference

New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.

21 January 2018

1 reference

Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome

21 January 2018

1 reference

Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).

21 January 2018

1 reference

Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset

21 January 2018

1 reference

The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer.

21 January 2018

1 reference

Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger.

21 January 2018

1 reference

Survival in women with MMR mutations and ovarian cancer: a multicentre study in Lynch syndrome kindreds

21 January 2018

1 reference

Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.

21 January 2018

1 reference

Increased risk for hereditary nonpolyposis colorectal cancer-associated synchronous and metachronous malignancies in patients with microsatellite instability-positive endometrial carcinoma lacking MLH1 promoter methylation

21 January 2018

1 reference

MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas

21 January 2018

1 reference

Carcinoma of the lower uterine segment: a newly described association with Lynch syndrome

21 January 2018

1 reference

Lynch syndrome--related endometrial carcinomas show a high frequency of nonendometrioid types and of high FIGO grade endometrioid types

21 January 2018

1 reference

Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities.

21 January 2018

1 reference

Comparison of clinical schemas and morphologic features in predicting Lynch syndrome in mutation-positive patients with endometrial cancer encountered in the context of familial gastrointestinal cancer registries.

21 January 2018

1 reference

Testing women with endometrial cancer to detect Lynch syndrome

21 January 2018

1 reference

Undifferentiated carcinoma of the endometrium

21 January 2018

1 reference

Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma: a new type of dedifferentiated carcinoma?

21 January 2018

1 reference

Are women with endocervical adenocarcinoma at risk for lynch syndrome? Evaluation of 101 cases including unusual subtypes and lower uterine segment tumors

21 January 2018

1 reference

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability

21 January 2018

1 reference

Prospective evaluation of molecular screening for Lynch syndrome in patients with endometrial cancer ≤ 70 years.

21 January 2018

1 reference

Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives

21 January 2018

1 reference

A two-antibody mismatch repair protein immunohistochemistry screening approach for colorectal carcinomas, skin sebaceous tumors, and gynecologic tract carcinomas

21 January 2018

1 reference

Utility of immunohistochemistry in predicting microsatellite instability in endometrial carcinoma

21 January 2018

1 reference

Lynch syndrome screening strategies among newly diagnosed endometrial cancer patients

21 January 2018

1 reference

Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR.

21 January 2018

1 reference

A cost-effectiveness analysis of prophylactic surgery versus gynecologic surveillance for women from hereditary non-polyposis colorectal cancer (HNPCC) Families

21 January 2018

1 reference

Clinicopathologic significance of defective DNA mismatch repair in endometrial carcinoma

21 January 2018

1 reference

Familial multiple cutaneous and uterine leiomyomas associated with papillary renal cell cancer.

21 January 2018

1 reference

Genetic testing by cancer site: uterus

21 January 2018

1 reference

Morphologic features of uterine leiomyomas associated with hereditary leiomyomatosis and renal cell carcinoma syndrome: a case report

21 January 2018

1 reference

Genetic testing by cancer site: ovary

21 January 2018

1 reference

Hereditary gynecologic cancers: risk assessment, counseling, testing and management

21 January 2018

1 reference

Sertoli cell tumors of the ovary: a clinicopathologic and immunohistochemical study of 54 cases

21 January 2018

1 reference

Ovarian Fibromas in Pediatric Patients With Basal Cell Nevus (Gorlin) Syndrome

21 January 2018

1 reference

Consensus statement from the first international colloquium on basal cell nevus syndrome (BCNS).

21 January 2018

1 reference

Sex cord-stromal tumors of the ovary and testis: their similarities and differences with consideration of selected problems

21 January 2018

1 reference

“BRCAness” Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated WithBRCA1andBRCA2Mutations

21 January 2018

1 reference

Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study

21 January 2018

1 reference

Germline BRCA1 and BRCA2 Mutations in Ovarian Cancer

21 January 2018

1 reference

Society of Gynecologic Oncologists Education Committee Statement on Risk Assessment for Inherited Gynecologic Cancer Predispositions☆

21 January 2018

1 reference

The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/HIS.12028

1 reference

28 August 2017

1 reference